Mahmoud Omidi, Ph.D., is a toxicologist and researcher based in Iran. He obtained his Ph.D. in Toxicology from Shiraz University of Medical Sciences and his MSc in Toxicology from Mazandaran University of Medical Sciences. Dr. Omidi’s research interests lie in developmental toxicology, mechanistic toxicology, and the interplay between Aryl hydrocarbon receptor (AHR) signaling and Wnt/β-Catenin signaling pathways.
Author Metrics
Scopus Profile
ORCID Profile
Dr. Omidi has an extensive publication record, with contributions to various peer-reviewed journals and conference proceedings. His research has been cited by peers in the field, reflecting the impact of his work in toxicology and related disciplines.
Citation Metrics
- Citations: 198
- Documents: 31
- h-index: 9
Mahmood Omidi, affiliated with the Hormozgan University of Medical Sciences in Bandar Abbas, Iran, has a significant research presence with 198 citations across 31 documents. His h-index, a measure of both productivity and citation impact, stands at 9, indicating that he has published at least 9 papers that have each received at least 9 citations.
Education
Dr. Omidi completed his Ph.D. and MSc in Toxicology from reputable medical universities in Iran. His educational background provides a strong foundation for his research endeavors in understanding the mechanisms of toxicity and developing strategies for mitigating adverse effects.
Research Focus
Dr. Omidi’s research primarily focuses on developmental toxicology, mechanistic toxicology, and the molecular pathways involved in toxicant-induced damage. He is particularly interested in the interplay between Aryl hydrocarbon receptor (AHR) signaling and Wnt/β-Catenin signaling pathways and their roles in developmental abnormalities and disease pathogenesis.
Professional Journey
After completing his education, Dr. Omidi embarked on a career in academia, teaching courses in pharmacology and toxicology at various universities in Iran. Simultaneously, he continued his research activities, contributing significantly to the field through publications, conference presentations, and collaborative projects.
Honors & Awards
Throughout his career, Dr. Omidi has received recognition for his contributions to toxicology research. His work has been honored with awards and accolades, reflecting the quality and impact of his scientific endeavors.
Publications Noted & Contributions
Dr. Omidi’s publications span a wide range of topics within toxicology, including the assessment of heavy metal toxicity, protective effects of natural compounds, and the evaluation of pharmaceutical agents on cellular function. His contributions have advanced our understanding of toxicant-induced damage and potential therapeutic interventions.
Protective Effects of Astaxanthin on Post-Thaw Sperm Quality in Normozoospermic Men
Published in: Andrologia, 2024-03-20
DOI: 10.1155/2024/2332443
Contributors: Afshin Mohammadi-Bardbori; Amir Shadboorestan; Ensieh Salehi; Mohammad Amin Rahimi; Elias Kargar-Abarghouei; Fardin Amidi; Jebreil Shamseddin; Mahmoud Omidi; Saleem Banihani
This study investigates the protective effects of astaxanthin on sperm quality after thawing in normozoospermic men.
Clinical significance of long non‐coding RNA ZEB2‐AS1 and EMT‐related markers in ductal and lobular breast cancer
Published in: Cancer Reports, 2023-05
DOI: 10.1002/cnr2.1826
Contributors: Mahboobeh Zarei; Kianoosh Malekzadeh; Mahmoud Omidi; Pegah Mousavi
This research explores the clinical significance of long non-coding RNA ZEB2-AS1 and epithelial-mesenchymal transition (EMT)-related markers in ductal and lobular breast cancer.
Assessment of the Cytotoxic Activity of Triphala: A Semisolid Traditional Formulation on HepG2 Cancer Cell Line
Published in: BioMed Research International, 2021-08-11
DOI: 10.1155/2021/6689568
Contributors: Ali Sahragard; Zohreh Alavi; Zohreh Abolhassanzadeh; Mahmoodreza Moein; Afshin Mohammadi-Bardbori; Mahmoud Omidi; Mohammad M. Zarshenas; Kazim Husain
This study assesses the cytotoxic activity of Triphala, a traditional formulation, on the HepG2 cancer cell line.
Effect of storage temperature on fungal growth and aflatoxin formation in oils extracted from wild almond nuts
Published in: Journal of Food Processing and Preservation, 2020-12-10
DOI: 10.1111/jfpp.14987
Contributors: Seyed Mohammad Bagher Hashemi; Motahareh Hashemi Moosavi; Seyed Hossein Asadi‐Yousefabad; Mahmoud Omidi; Amin Mousavi Khaneghah
This research investigates the effect of storage temperature on fungal growth and aflatoxin formation in oils extracted from wild almond nuts.
Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial
Published in: Gastroenterology Research and Practice, 2020-11-12
DOI: 10.1155/2020/5152736
Contributors: Ghasem Bordbar; Mohammad Bagher Miri; Mahmoud Omidi; Saeed Shoja; Malihe Akhavan; Eiji Sakai
This clinical trial compares the effectiveness of a novel herbal medicine with omeprazole in treating functional dyspepsia.
Research Timeline
Dr. Omidi’s research journey has evolved over the years, from his early investigations into cytotoxicity and mitochondrial function to his current focus on developmental toxicology and molecular signaling pathways. His research timeline reflects a progressive exploration of toxicological mechanisms and their implications for human health.
Collaborations and Projects
Dr. Omidi has engaged in collaborative projects with colleagues both domestically and internationally. These collaborations have enabled him to leverage diverse expertise and resources to address complex research questions and enhance the impact of his work in the field of toxicology.
